Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

HSV-1 and HSV-2 Seroprevalence in the United States Among Asymptomatic Women Unaware of any Herpes Simplex Virus Infection (Herpevac Trial for Women)

Go back to Resources

HSV-1 and HSV-2 Seroprevalence in the United States Among Asymptomatic Women Unaware of any Herpes Simplex Virus Infection (Herpevac Trial for Women)

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Finding Your First Industry Job

Go back to Resources

Finding Your First Industry Job

Authors:

Secondary:

Location:

URL:

Go back to Resources

Fetal Antiepileptic Drug Exposure: Adaptive and Emotional/Behavioral Functioning at Age 6 Years

Go back to Resources

Fetal Antiepileptic Drug Exposure: Adaptive and Emotional/Behavioral Functioning at Age 6 Years

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Factors Predicting Health Related Quality of Life in Pediatric Liver Transplant Recipients in the Functional Outcomes Group

Go back to Resources

Factors Predicting Health Related Quality of Life in Pediatric Liver Transplant Recipients in the Functional Outcomes Group

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Evaluation of the Mercy TAPE: Performance Against the Standard for Pediatric Weight

Go back to Resources

Evaluation of the Mercy TAPE: Performance Against the Standard for Pediatric Weight

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Evaluation of Optimized Digital Fundus Reflex Photographs for Lens Opacities in the Age-Related Eye Disease Study 2: AREDS2 Report 7

Go back to Resources

Evaluation of Optimized Digital Fundus Reflex Photographs for Lens Opacities in the Age-Related Eye Disease Study 2: AREDS2 Report 7

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Evaluation of a Genomic-Based Prognostic Test for Metastasis in High-Risk Post-Prostatectomy Patients: Does it Impact Physician Decision Making

Go back to Resources

Evaluation of a Genomic-Based Prognostic Test for Metastasis in High-Risk Post-Prostatectomy Patients: Does it Impact Physician Decision Making

Authors:

Secondary:

Location:

URL:

Go back to Resources

Circularity Index as a Risk Factor for Progression of Geographic Atrophy

Go back to Resources

Circularity Index as a Risk Factor for Progression of Geographic Atrophy

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report

Go back to Resources

Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report

Authors:

Secondary:

URL:

Abstract:

Go back to Resources

Changes in Clearance, Volume and Bioavailability of Immunosuppressants When Given With HAART in HIV-1 Infected Liver and Kidney Transplant Recipients

Go back to Resources

Changes in Clearance, Volume and Bioavailability of Immunosuppressants When Given With HAART in HIV-1 Infected Liver and Kidney Transplant Recipients

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 213
  • Page 214
  • Page 215
  • Page 216
  • Current page 217
  • Page 218
  • Page 219
  • Page 220
  • Page 221
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification